These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11266932)

  • 21. Pharmacokinetics of SDZ RAD and cyclosporin including their metabolites in seven kidney graft patients after the first dose of SDZ RAD.
    Kirchner GI; Winkler M; Mueller L; Vidal C; Jacobsen W; Franzke A; Wagner S; Blick S; Manns MP; Sewing KF
    Br J Clin Pharmacol; 2000 Nov; 50(5):449-54. PubMed ID: 11069439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Everolimus. Novartis.
    Dumont FJ
    Curr Opin Investig Drugs; 2001 Sep; 2(9):1220-34. PubMed ID: 11717808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders.
    Majewski M; Korecka M; Kossev P; Li S; Goldman J; Moore J; Silberstein LE; Nowell PC; Schuler W; Shaw LM; Wasik MA
    Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4285-90. PubMed ID: 10759564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunophilins: beyond immunosuppression.
    Hamilton GS; Steiner JP
    J Med Chem; 1998 Dec; 41(26):5119-43. PubMed ID: 9857082
    [No Abstract]   [Full Text] [Related]  

  • 25. Chemical modification of rapamycin: the discovery of SDZ RAD.
    Sedrani R; Cottens S; Kallen J; Schuler W
    Transplant Proc; 1998 Aug; 30(5):2192-4. PubMed ID: 9723437
    [No Abstract]   [Full Text] [Related]  

  • 26. One pathway, many products.
    Fischbach MA; Clardy J
    Nat Chem Biol; 2007 Jul; 3(7):353-5. PubMed ID: 17576415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined immunosuppression with cyclosporine (neoral) and SDZ RAD in non-human primate lung transplantation: systematic pharmacokinetic-based trials to improve efficacy and tolerability.
    Hausen B; Ikonen T; Briffa N; Berry GJ; Christians U; Robbins RC; Hook L; Serkova N; Benet LZ; Schuler W; Morris RE
    Transplantation; 2000 Jan; 69(1):76-86. PubMed ID: 10653384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proliferation signal inhibitors for the treatment of refractory autoimmune rheumatic diseases: a new therapeutic option.
    Yoon KH
    Ann N Y Acad Sci; 2009 Sep; 1173():752-6. PubMed ID: 19758225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [mTOR and FTY 720 inhibitors].
    Morel D
    Presse Med; 2001 Sep; 30(24 Pt 2):35-7. PubMed ID: 11577586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of glomerular and tubular functions in renal transplant patients receiving cyclosporine A in combination with either sirolimus or everolimus.
    Kamar N; Allard J; Ribes D; Durand D; Ader JL; Rostaing L
    Clin Nephrol; 2005 Feb; 63(2):80-6. PubMed ID: 15730049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The macrolide SDZ RAD is efficacious in a nonhuman primate model of allotransplantation.
    Schuurman HJ; Schuler W; Ringers J; Jonker M
    Transplant Proc; 1998 Aug; 30(5):2198-9. PubMed ID: 9723439
    [No Abstract]   [Full Text] [Related]  

  • 32. Structural identification of SAR-943 metabolites generated by human liver microsomes in vitro using mass spectrometry in combination with analysis of fragmentation patterns.
    Strom T; Shokati T; Klawitter J; Klawitter J; Hoffman K; Schiebel HM; Christians U
    J Mass Spectrom; 2011 Jul; 46(7):615-24. PubMed ID: 21671437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery.
    Koster RA; Alffenaar JW; Greijdanus B; Uges DR
    Talanta; 2013 Oct; 115():47-54. PubMed ID: 24054560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age and sex differences in the effects of the immunosuppressants cyclosporine, sirolimus and everolimus on rat brain metabolism.
    Gottschalk S; Cummins CL; Leibfritz D; Christians U; Benet LZ; Serkova NJ
    Neurotoxicology; 2011 Jan; 32(1):50-7. PubMed ID: 21075140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of QMS everolimus assay using Hitachi 917 Analyzer: comparison with liquid chromatography/mass spectrometry.
    Dasgupta A; Davis B; Chow L
    Ther Drug Monit; 2011 Apr; 33(2):149-54. PubMed ID: 21266941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of sirolimus metabolites in pediatric solid organ transplant recipients.
    Filler G; Bendrick-Peart J; Strom T; Zhang YL; Johnson G; Christians U
    Pediatr Transplant; 2009 Feb; 13(1):44-53. PubMed ID: 18482220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability of sirolimus and everolimus measured by immunoassay techniques in whole blood samples from kidney transplant patients.
    Capone D; Gentile A; Polichetti G; Federico S; Sabbatini M; Acampora A; Basile V; Pieri M; Tarantino G
    Int J Immunopathol Pharmacol; 2008; 21(2):297-307. PubMed ID: 18547473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between everolimus blood concentration assessed using the Innofluor Certican Fluorescence Polarization Immunoassay and the Architect i System sirolimus chemiluminescent microparticle immunoassay.
    Coentrão L; Carvalho C; Sampaio S; Oliveira JG; Pestana MI
    Transplant Proc; 2010 Jun; 42(5):1867-9. PubMed ID: 20620539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Everolimus: immunosuppression with antilymphoproliferative therapy].
    Pascual J
    Nefrologia; 2004; 24(2):112-23. PubMed ID: 15219086
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of performance of new, isotopically labeled internal standard ([13c2d4]RAD001) for everolimus using a novel high-performance liquid chromatography tandem mass spectrometry method.
    Korecka MA; Patel R; Shaw LM
    Ther Drug Monit; 2011 Aug; 33(4):460-3. PubMed ID: 21743385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.